We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+22.18%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$348M
AUM Growth
+$62.6M
Cap. Flow
+$45.9M
Cap. Flow %
13.19%
Top 10 Hldgs %
43.07%
Holding
103
New
27
Increased
20
Reduced
28
Closed
24

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$12.3M
2
SRPT icon
Sarepta Therapeutics
SRPT
+$4M
3
MZOR
Mazor Robotics Ltd.
MZOR
+$3.63M
4
ALB icon
Albemarle
ALB
+$3.45M
5
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$3.41M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$4.67M
2
ADSK icon
Autodesk
ADSK
+$4.19M
3
MDCO
Medicines Co
MDCO
+$4.13M
4
Z icon
Zillow
Z
+$3.6M
5
SHOP icon
Shopify
SHOP
+$2.96M

Sector Composition

Rank Sector Weight
1 Healthcare 27.47%
2 Communication Services 13.17%
3 Technology 13.06%
4 Consumer Discretionary 5.1%
5 Materials 2.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDCO
76
CALL
DELISTED
Medicines Co
MDCO
$740K 0.21%
+20,000
New +$737K
ESPR
77
DELISTED
Esperion Therapeutics
ESPR
$686K 0.2%
+13,700
New +$661K
SIOX
78
CALL
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$174K 0.05%
+3,175
New +$536K
REED
79
DELISTED
Reeds, Inc. Common Stock
REED
$62K 0.02%
+563
New +$54.9K
ADSK icon
80
PUT
Autodesk
ADSK
$49.5B
– –
-27,500
Closed -$2.77M
APPN icon
81
Appian
APPN
$1.98B
– –
-120,000
Closed -$2.18M
BHC icon
82
CALL
Bausch Health
BHC
$2.57B
– –
-120,000
Closed -$2.08M
EPAM icon
83
EPAM Systems
EPAM
$5.51B
– –
-19,000
Closed -$1.6M
GKOS icon
84
Glaukos
GKOS
$9.83B
– –
-18,000
Closed -$746K
HRTX icon
85
CALL
Heron Therapeutics
HRTX
$93.9M
– –
-60,000
Closed -$831K
IRWD icon
86
CALL
Ironwood Pharmaceuticals
IRWD
$696M
– –
-47,760
Closed -$755K
IRWD icon
87
Ironwood Pharmaceuticals
IRWD
$696M
– –
-107,460
Closed -$1.7M
META icon
88
PUT
Meta Platforms (Facebook)
META
$1.42T
– –
-20,000
Closed -$3.02M
REGN icon
89
Regeneron Pharmaceuticals
REGN
$78.5B
– –
-9,500
Closed -$4.67M
SAGE
90
DELISTED
Sage Therapeutics
SAGE
– –
-7,000
Closed -$550K
SHOP icon
91
Shopify
SHOP
$152B
– –
-340,000
Closed -$2.96M
SHW icon
92
Sherwin-Williams
SHW
$82.7B
– –
-21,000
Closed -$2.46M
Z icon
93
Zillow
Z
$7.79B
– –
-73,400
Closed -$3.6M
SLCA
94
CALL
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
– –
-24,500
Closed -$869K
DOOR
95
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
– –
-15,000
Closed -$1.13M
SIOX
96
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
– –
-8,750
Closed -$1.48M
OTIC
97
DELISTED
Otonomy, Inc.
OTIC
– –
-84,000
Closed -$1.58M
CLVS
98
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-29,000
Closed -$2.71M
MDSO
99
DELISTED
Medidata Solutions, Inc.
MDSO
– –
-32,500
Closed -$2.54M
TSRO
100
CALL
DELISTED
TESARO, Inc.
TSRO
– –
-6,700
Closed -$937K
1 2 3
4
5

Similar funds

AGA
Arkos Global Advisors Houston, Texas $797M AUM 15.28% 1-Year Est. Return
RIM
Rovida Investment Management Grand Cayman, Cayman Islands $797M AUM 111.83% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $797M AUM 4.79% 1-Year Est. Return
CAM
CenterStar Asset Management Chicago, Illinois $797M AUM 28.71% 1-Year Est. Return
Legacy Financial Group (Iowa)
Legacy Financial Group (Iowa) Des Moines, Iowa $795M AUM 12.87% 1-Year Est. Return
LSA
L & S Advisors Los Angeles, California $795M AUM 52.77% 1-Year Est. Return
GWA
Geometric Wealth Advisors Washington, District of Columbia $799M AUM 22.19% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

Atika Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Atika Capital Management held 103 positions worth $348M, up 22% from $285M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Atika Capital Management deployed $45.9M of net new capital in Q3 2017, opening 27 new positions and adding to 20 existing holdings. Its largest new stake was Sarepta Therapeutics: 100,000 shares worth $4.54M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 28% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Autodesk, an estimated $4.19M trimmed.

  • Atika Capital Management's largest Q3 2017 buy was Sarepta Therapeutics: 100,000 shares worth $4.54M.
  • Atika Capital Management added most to Intuitive Surgical in Q3 2017, an estimated $12.3M increase.
  • Atika Capital Management's biggest Q3 2017 reduction was Autodesk, cutting an estimated $4.19M.
  • Atika Capital Management fully exited Regeneron Pharmaceuticals in Q3 2017, selling an estimated $4.67M.
  • Atika Capital Management's ten largest holdings make up 43% of its $348M portfolio in Q3 2017.
  • Atika Capital Management opened 27 new positions and closed 24 in Q3 2017.
  • Atika Capital Management's portfolio value rose 22% quarter-over-quarter to $348M.

Based on Atika Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.